Latest 10-K annual reports

NASDAQ
TOMI Environmental Solutions files an amendment to its annual report on Form 10-K to correct file references and include exhibits inadvertently omitted in the original filing.
NASDAQ
Shattuck Labs files an amendment to its 2024 Annual Report on Form 10-K/A solely to include certain XBRL interactive data that was inadvertently omitted in Amendment No. 1.
NASDAQ
Perma-Pipe International Holdings' 2025 10-K filing highlights its insider trading policy, risk factors, and a year-over-year increase in net sales driven by higher volumes in the Middle East and Canada.
NASDAQ
BT Brands, Inc. files an amendment to its annual report on Form 10-K to correct typographical errors related to treasury shares and the number of issued shares presented in the financial statements.
OTC.Pink
Vocodia Holdings Corp files an amendment to its 10-K report to correct errors related to auditor consent letters and the filing date.
AMEX
InnSuites Hospitality Trust reports its Fiscal Year 2025 results, highlighting revenue improvements and strategic diversification efforts despite facing increased operating expenses and a net loss.
NASDAQ
Navitas Semiconductor files an amendment to its annual report on Form 10-K to include previously omitted information from Part III, concerning directors, executive officers, corporate governance, and executive compensation.
OQB
Jones Soda Co. files an amendment to its 2024 Annual Report on Form 10-K, primarily to restate information in Part III regarding directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, and principal accounting fees.
NASDAQ
Reading International files an amendment to its 2024 Annual Report on Form 10-K/A to include new exhibits and information required by Items 10 through 14 of Part III.
NASDAQ
Fundamental Global Inc. files an amendment to its annual report on Form 10-K to update information in Part III regarding directors, executive officers, and corporate governance.
NASDAQ
GameSquare Holdings files an amendment to its annual report on Form 10-K to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, accounting fees, and updated exhibits.
NASDAQ
Silence Therapeutics files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.
AMEX
Catheter Precision files an amendment to its 2024 annual report to include previously omitted information regarding related party transactions.
NASDAQ
TPI Composites files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, corporate governance, and executive compensation.
NASDAQ
ASP Isotopes Inc. files an amendment to its 2024 Annual Report on Form 10-K/A to include information previously omitted regarding directors, executive compensation, and corporate governance.
Eyenovia, Inc. files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.
iCAD, Inc. files an amendment to its 2024 annual report on Form 10-K to restate information regarding directors, executive compensation, security ownership, related transactions, and accounting fees, while also addressing certifications and the pending merger with RadNet.
NASDAQ
Adagio Medical Holdings files an amendment to its annual report to include information on directors, executive officers, corporate governance, and updated exhibits.
Regulus Therapeutics files an amendment to its annual report on Form 10-K to include information required in Part III, which was not initially included due to the delay in filing the definitive proxy statement.
AMEX
The Arena Group Holdings, Inc. files an amendment to its Form 10-K for the year ended December 31, 2024, to include previously omitted information regarding directors, executive officers, compensation, security ownership, related transactions, and principal accountant fees.
Rein Therapeutics files an amendment to its annual report on Form 10-K to include previously omitted information regarding directors, executive compensation, and corporate governance.
NASDAQ
Generation Income Properties files an amendment to its 2024 annual report on Form 10-K to include previously omitted information and exhibits.
AMEX
Nuburu, Inc. files an amendment to its 2024 annual report, updating information on funding agreements, corporate governance, and a strategic shift following a foreclosure and subsequent asset diversification.
OTC.Pink
ProPhase Labs files an amendment to its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, principal accountant fees, and a subsequent event relating to executive salary deferrals.
NASDAQ
Power Solutions International files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive officers, corporate governance, and executive compensation.
OTC.Pink
Marky Corp., a social media marketing information services provider, saw revenue growth but also a larger net loss in the fiscal year ending January 31, 2025, alongside a change in company control.
NASDAQ
Solidion Technology files an amendment to its annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.
NYSE
Boston Omaha Corporation files an amendment to its 2024 Annual Report on Form 10-K to include information required in Part III regarding directors, executive officers, compensation, and related matters.
Complete Solaria reports a net loss of $56.5 million for fiscal year 2024 and identifies conditions raising substantial doubt about its ability to continue as a going concern.
OQB
SpringBig Holdings files an amendment to its 2024 Annual Report on Form 10-K, primarily to include Part III information regarding directors, executive officers, and corporate governance.